Golden Biotechnology Corporation (TPEX: 4132)
Taiwan
· Delayed Price · Currency is TWD 17.35
-0.25 (-1.42%)
Jan 20, 2025, 2:59 PM CST
Golden Biotechnology Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | -379.32 | -361.64 | -271.88 | -443.84 | -391.38 | -285.12 | Upgrade
|
| Depreciation & Amortization | 46.53 | 49.25 | 49.95 | 49.38 | 54.93 | 64.12 | Upgrade
|
| Other Amortization | 1.76 | 1.78 | 1.26 | 1.81 | 1.98 | 1.89 | Upgrade
|
| Loss (Gain) From Sale of Assets | -1.08 | -1.01 | -0.44 | - | 0.48 | - | Upgrade
|
| Asset Writedown & Restructuring Costs | 1.68 | 1.68 | 2.23 | 10.01 | 27.24 | 9.94 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | - | 0.23 | - | 1.22 | - | Upgrade
|
| Stock-Based Compensation | - | - | - | 21.7 | - | - | Upgrade
|
| Provision & Write-off of Bad Debts | -0.01 | - | - | - | -0.1 | -0.34 | Upgrade
|
| Other Operating Activities | 0.39 | -0.62 | -1.25 | 6.12 | 3.62 | 0.59 | Upgrade
|
| Change in Accounts Receivable | 0.84 | 1.02 | -0.57 | -0.77 | 2.17 | 1.91 | Upgrade
|
| Change in Inventory | 17.61 | -0.5 | 70.53 | 71.74 | 32.31 | -12.82 | Upgrade
|
| Change in Accounts Payable | 0.52 | 0.71 | 0.45 | -0.77 | -0.29 | -0.42 | Upgrade
|
| Change in Unearned Revenue | 0.33 | 2 | -113.82 | 114.13 | 0.01 | -0.03 | Upgrade
|
| Change in Other Net Operating Assets | 59.67 | 36.03 | 17.41 | -27.47 | 8.23 | -2.7 | Upgrade
|
| Operating Cash Flow | -251.09 | -271.32 | -245.9 | -197.96 | -259.6 | -222.98 | Upgrade
|
| Capital Expenditures | -0.83 | -4.89 | -14.4 | -9.34 | -9.42 | -10.89 | Upgrade
|
| Sale of Property, Plant & Equipment | 1.19 | 1.52 | 0.91 | - | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | -3.9 | -3.09 | -3.64 | -0.81 | -1.24 | -1 | Upgrade
|
| Investment in Securities | - | - | - | - | - | 50 | Upgrade
|
| Other Investing Activities | -17.02 | -12.19 | 80.6 | -103.87 | -3.47 | -10.06 | Upgrade
|
| Investing Cash Flow | -20.55 | -18.64 | 63.47 | -114.02 | -14.14 | 28.05 | Upgrade
|
| Short-Term Debt Issued | - | - | - | 72 | 50 | - | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | 13 | - | Upgrade
|
| Total Debt Issued | 36.81 | - | - | 72 | 63 | - | Upgrade
|
| Short-Term Debt Repaid | - | - | -2 | - | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -21.8 | -24.32 | -33.73 | -37.66 | -33.54 | Upgrade
|
| Total Debt Repaid | -22.97 | -21.8 | -26.32 | -33.73 | -37.66 | -33.54 | Upgrade
|
| Net Debt Issued (Repaid) | 13.84 | -21.8 | -26.32 | 38.27 | 25.34 | -33.54 | Upgrade
|
| Issuance of Common Stock | - | - | - | 580 | 539.21 | 118.69 | Upgrade
|
| Financing Cash Flow | 13.84 | -21.8 | -26.32 | 618.27 | 564.55 | 85.15 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.46 | -0.85 | 0.67 | -2.65 | -0.69 | -0.3 | Upgrade
|
| Net Cash Flow | -258.26 | -312.6 | -208.08 | 303.64 | 290.12 | -110.08 | Upgrade
|
| Free Cash Flow | -251.92 | -276.2 | -260.3 | -207.31 | -269.02 | -233.88 | Upgrade
|
| Free Cash Flow Margin | -438.18% | -435.45% | -119.50% | -253.53% | -302.87% | -280.79% | Upgrade
|
| Free Cash Flow Per Share | -1.77 | -1.94 | -1.83 | -1.56 | -2.14 | -2.03 | Upgrade
|
| Cash Interest Paid | 5.92 | 6.73 | 4.08 | 3.69 | 3.13 | 3.14 | Upgrade
|
| Cash Income Tax Paid | 0.78 | 0.91 | 1.37 | 3.92 | 0.44 | 0.67 | Upgrade
|
| Levered Free Cash Flow | -119.21 | -153.2 | -98.85 | -132.66 | -168.97 | -79.98 | Upgrade
|
| Unlevered Free Cash Flow | -114.96 | -148.99 | -96.3 | -130.36 | -166.38 | -77.33 | Upgrade
|
| Change in Net Working Capital | -76.61 | -36.44 | -56.02 | -71.82 | -4.84 | -37.6 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.